Position in ASND
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$205,032,885
-$13,838,143 QoQ
Shares Held
896,397
-12.7% QoQ
Ownership
1.37%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 98.068489742826.ToString("F0")%
Shared 0.ToString("F0")%
None 1.9315102571739975.ToString("F0")%
Common Shares in ASND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PRINCIPAL FINANCIAL GROUP INC holds $1,683,587,850 across 95 Biotechnology names. ASND ranks #1 (12.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
This page
|
896,397 | $205,032,885 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
426,523 | $190,459,579 | |
| 3 | INSM |
INSMED Inc
|
916,464 | $149,860,192 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
1,330,415 | $98,796,617 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
120,425 | $93,045,171 | |
| 6 | GPCR |
Structure Therapeutics Inc.
|
1,753,764 | $84,531,424 | |
| 7 | CYTK |
Cytokinetics Inc
|
1,093,485 | $72,071,595 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
350,488 | $59,239,481 |
All Filings in ASND
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $205,032,885 | 896,397 | Shares | Defined | 2026-05-04 | |
| 2025-12-31 | $218,871,028 | 1,026,407 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $157,790,924 | 793,677 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $4,852,821 | 28,116 | Shares | Defined | 2025-08-08 | |
| No filing history on record for this holder in this stock. | ||||||